Cargando…

Lactoferricin B reverses cisplatin resistance in head and neck squamous cell carcinoma cells through targeting PD‐L1

Head and neck squamous cell carcinoma (HNSCC) ranks among the top most common cancers with a poor prognosis. The mechanism of chemoresistance is still not well known. This study is to investigate the programmed death‐ligand 1 (PD‐L1) expression in HNSCC, and test the effect of lactoferricin B (Lfcin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Pei, Liu, Jinzhong, Li, Wenlu, Li, Shanshan, Han, Xinguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051176/ https://www.ncbi.nlm.nih.gov/pubmed/29761938 http://dx.doi.org/10.1002/cam4.1529

Ejemplares similares

Hypoxia promotes the tolerogenic phenotype of plasmacytoid dendritic cells in head and neck squamous cell carcinoma
por: Fan, Cui, et al.
Publicado: (2021)

Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review
por: Swartz, Justin E, et al.
Publicado: (2015)

Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas
por: Wong, Nathan, et al.
Publicado: (2016)

The prognostic role of C‐reactive protein in patients with head and neck squamous cell carcinoma: A meta‐analysis
por: Chen, Yanglan, et al.
Publicado: (2020)

Proliferative exhausted CD8(+) T cells exacerbate long-lasting anti-tumor effects in human papillomavirus-positive head and neck squamous cell carcinoma
por: Cheng, Danni, et al.
Publicado: (2023)

Prognostic significance of PD‐L2 expression in patients with oral squamous cell carcinoma—A comparison to the PD‐L1 expression profile
por: Weber, Manuel, et al.
Publicado: (2019)

FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma
por: Liang, Huazhen, et al.
Publicado: (2021)

Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR‐421 and E‐cadherin
por: Ji, Yefeng, et al.
Publicado: (2020)

Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck
por: Zandberg, Dan P, et al.
Publicado: (2021)

Comparing high‐dose cisplatin with cisplatin‐based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC)
por: Furqan, Muhammad, et al.
Publicado: (2019)

Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment
por: Nicolas-Boluda, Alba, et al.
Publicado: (2021)

Phase II trial of individualized/dynamic cisplatin regimens for definitive concurrent chemoradiation therapy in patients with head and neck squamous cell carcinoma
por: Ahn, Dongbin, et al.
Publicado: (2020)

Mitochondrial DNA copy number is associated with risk of head and neck squamous cell carcinoma in Chinese population
por: Wang, Lihua, et al.
Publicado: (2018)

PD‐1/PD‐L1 inhibitors‐based treatment for advanced renal cell carcinoma: Mechanisms affecting efficacy and combination therapies
por: Ding, Lei, et al.
Publicado: (2021)

Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
por: Osman, Abdullah A., et al.
Publicado: (2023)

Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low‐dose fraction radiation
por: Zhao, Lili, et al.
Publicado: (2019)

Concordance of PD‐1 and PD‐L1 (B7‐H1) in paired primary and metastatic clear cell renal cell carcinoma
por: Eckel‐Passow, Jeanette E., et al.
Publicado: (2019)

HOTAIRM1 competed endogenously with miR‐148a to regulate DLGAP1 in head and neck tumor cells
por: Zheng, Mei, et al.
Publicado: (2018)

PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus
por: Fassan, Matteo, et al.
Publicado: (2019)

The Tumor Immune Microenvironment Architecture Correlates with Risk of Recurrence in Head and Neck Squamous Cell Carcinoma
por: Weed, Donald T., et al.
Publicado: (2023)

An immune‐related seven‐lncRNA signature for head and neck squamous cell carcinoma
por: Chen, Yue, et al.
Publicado: (2021)

An integrated genomic approach identifies follistatin as a target of the p63-epidermal growth factor receptor oncogenic network in head and neck squamous cell carcinoma
por: Oyelakin, Akinsola, et al.
Publicado: (2023)

Apoptin‐derived peptide reverses cisplatin resistance in gastric cancer through the PI3K–AKT signaling pathway
por: Zhou, Danyang, et al.
Publicado: (2018)

The effects and safety of PD‐1/PD‐L1 inhibitors on head and neck cancer: A systematic review and meta‐analysis
por: Wang, Bi‐Cheng, et al.
Publicado: (2019)

Adherence of head and neck squamous cell carcinoma patients to tumor board recommendations
por: Rangabashyam, Mahalakshmi S., et al.
Publicado: (2020)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Decitabine Rescues Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma
por: Viet, Chi T., et al.
Publicado: (2014)

FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis
por: Huang, Junjie, et al.
Publicado: (2021)

Targeting phosphodiesterase 3B enhances cisplatin sensitivity in human cancer cells
por: Uzawa, Katsuhiro, et al.
Publicado: (2013)

Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma
por: Chen, Jin‐Hua, et al.
Publicado: (2016)

MUC1 as a target for CAR‐T therapy in head and neck squamous cell carinoma
por: Mei, Zi, et al.
Publicado: (2019)

An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma
por: Chen, Dayang, et al.
Publicado: (2021)

Metformin and 4SC‐202 synergistically promote intrinsic cell apoptosis by accelerating ΔNp63 ubiquitination and degradation in oral squamous cell carcinoma
por: He, Yuan, et al.
Publicado: (2019)

Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker
por: Wang, Zhengyi, et al.
Publicado: (2020)

PD-L1 expression in anogenital and oropharyngeal squamous cell carcinomas associated with different clinicopathological features, HPV status and prognosis: a meta-analysis
por: Qin, Yuan, et al.
Publicado: (2021)

MicroRNA-21 induces cisplatin resistance in head and neck squamous cell carcinoma
por: Sheng, Shuyan, et al.
Publicado: (2022)

Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations
por: Lopez-Ayllon, Blanca D, et al.
Publicado: (2014)

Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
por: KjellÃ©n, E., et al.
Publicado: (1989)

Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
por: Griso, Ana Belén, et al.
Publicado: (2022)

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
por: Rades, Dirk, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nl7i5og3qhe0f858rb0kfg3ioq